Position history for Holocene Advisors, LP's holdings in REGENERON PHARMACEUTICALS
Holocene Advisors, LP holds 460,723 shares of REGN (REGENERON PHARMACEUTICALS), worth $355.6M as of 2025-Q4. The position was increased (++203.6% shares). REGN represents 0.7% of Holocene Advisors, LP's portfolio.
Current Value
$355.6M
Current Shares
460,723
Total Value Change
+$355.6M
Total Shares Change
+460,723
Other major holders of REGN: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 460,723 |
+203.6% |
| $355.6M |
| 0.7% |
| $773.94 |
71 |
| 2025-Q3 | New | 151,733 | - | $85.3M | 0.2% | $560.05 | 49 |
| 2024-Q2 | Exited | 0 | -100.0% | $0 | 0.0% | $1,045.23 | 0 |